Menu

Former US Energy Secretary to Lead AAAS

Steven Chu, the president-elect of the scientific organization, is a Nobel laureate and physicist at Stanford University.

Jan 10, 2018
Diana Kwon

WIKIMEDIA, THE ROYAL SOCIETY

The American Association for the Advancement of Science (AAAS) announced Steven Chu, a professor of physics and molecular and cellular physiology at Stanford University, as the society’s president-elect yesterday (January 9). Chu served as the Secretary of Energy during President Barack Obama’s first term in office.

“Never has there been a more important time than today for AAAS to communicate the advances in science, the methods we use to acquire this knowledge and the benefits of these discoveries to the public and our policymakers,” Chu says in his candidacy statement (via AAAS).

As Energy Secretary, Chu oversaw efforts to promote renewable energy technologies, such as solar panels and electric vehicles. “He had a substantial impact on changing research in the department, although mainly in terms of applied research,” Robert McKeown, deputy director for science at the Thomas Jefferson National Accelerator Facility, told physicsworld.com in 2013.

Chu had faced criticism, particularly from congressional Republications, who condemned, among other things, his decision to approve a $528-million government loan to Solyndra, a solar panel manufacturer that later went bankrupt. He resigned as US Energy Secretary in 2013, after four years in office.

In 1997, Chu shared the Nobel Prize in Physics with physicists Claude Cohen-Tannoudji and William Phillips for developing a technique to cool atoms and trap them with laser light.

Chu will start his three-year term with AAAS, which includes a year as president-elect, a year as president, and a year as chair of the society’s board of directors, in February. Margaret Hamburg, the current president-elect and the current foreign secretary of the National Academy of Medicine, will begin her term as president that month. 

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.